TrialAntimicrobial agents and chemotherapy2010

New fixed-dose artesunate-mefloquine formulation against multidrug-resistant Plasmodium falciparum in adults: a comparative phase IIb safety and pharmacokinetic study with standard-dose nonfixed artesunate plus mefloquine.

S Krudsood et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.